Article
Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis.
BMC medical ethics - 21 Oct 2020
Gustavsson Erik, Galvis Giovanni, Juth Niklas
Abstract excerpt
BACKGROUND: Genetic testing is moving from targeted investigations of monogenetic diseases to broader testing that may provide more information. For example, recent health economic studies of genetic testing for an increased risk of breast cancer suggest that it is associated with higher cost-effectiveness to screen for pathogenic variants in a seven gene panel rather than the usual two gene test for variants in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
